Steris Plc Revenue Growth Rates (STE), Current and Historic Growth - CSIMarket
CSIMarket
 


Steris Plc  (NYSE: STE)
 

STE's Revenue Growth by Quarter and Year

Steris Plc's Revenue results by quarter and year




STE Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter March 1,588.30
3rd Quarter December 1,496.20
2nd Quarter September 1,460.30
1st Quarter June 1,391.10
FY 5,935.90

STEs Annual Revenue
Steris Plc's Revenue in the fiscal year 2026 $ 5,935.90 millions
Steris Plc's Revenue in the fiscal year 2025 $ 5,459.52 millions
Steris Plc's Revenue in the fiscal year 2024 $ 5,138.70 millions
Steris Plc's Revenue in the fiscal year 2023 $ 4,957.84 millions
Steris Plc's Revenue in the fiscal year 2018 $ 2,620.00 millions




STE Revenue fourth quarter 2026 Y/Y Growth Comment
Steris Plc reported Revenue growth of 7.28% year on year in the fourth quarter 2026, to $ 1,588.30 millions, this is lower than Steris Plc's recent average Revenue increase of 17.73%.

Looking into fourth quarter 2026 results within Medical Equipment & Supplies industry 111 other companies have achieved higher Revenue growth. While Steris Plc' s Revenue increase of 7.28% ranks overall at the positon no. 2146 in the fourth quarter 2026.




STE Revenue ( Y/Y Growth %) 2026
2025 2024 2023
4th Quarter March 7.28 % 4.31 % 10.78 % 84.02 %
3rd Quarter December 9.17 % 5.61 % 16.66 % 63.84 %
2nd Quarter September 9.89 % 7.33 % 13.5 % 70.79 %
1st Quarter June 8.72 % 8.12 % 12.53 % 46.88 %
FY   8.73 % 6.24 % 13.28 % -

Financial Statements
Steris Plc's fourth quarter 2026 Revenue $ 1,588.30 millions STE's Income Statement
Steris Plc's fourth quarter 2025 Revenue $ 1,480.53 millions Quarterly STE's Income Statement


STE Revenue (Quarter on Quarter Growth %)

2026
2025 2024 2023
4th Quarter March 6.16 % 8.02 % 9.38 % 15.18 %
3rd Quarter December 2.46 % 3.13 % 4.81 % 1.97 %
2nd Quarter September 4.97 % 3.86 % 4.63 % 3.74 %
1st Quarter June -6.04 % -9.86 % -7.64 % 51.05 %
FY (Year on Year)   8.73 % 6.24 % 13.28 % -




Revenue fourth quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #112
Healthcare Sector #318
Overall #2146

Revenue Y/Y Growth Statistics
High Average Low
81.61 % 17.73 % -6.58 %
(Mar 31 2023)   (Dec 31 2017)
Revenue fourth quarter 2026 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #112
Healthcare Sector #318
Overall #2146
Revenue Y/Y Growth Statistics
High Average Low
81.61 % 17.73 % -6.58 %
(Mar 31 2023)   (Dec 31 2017)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Steris Plc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
35.08 % 0.39 % -100 %
(Mar 31 2016)  


STE's IV. Quarter Q/Q Revenue Comment
Steris Plc achieved in the IV. Quarter 2026 above company average sequential Revenue increase of 6.16%, to $ 1,588.30 millions, from $1,496.20 millions in the third quarter.

Within Medical Equipment & Supplies industry 29 other companies have achieved higher Revenue quarter on quarter growth. While Steris Plc's Revenue growth quarter on quarter, overall rank is 863.


Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #30
Healthcare Sector #124
Overall #863
Revenue Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #30
Healthcare Sector #124
Overall #863
Revenue Q/Q Growth Statistics
High Average Low
35.08 % 0.39 % -100 %
(Mar 31 2016)  


STE's IV. Quarter Q/Q Revenue Comment
Steris Plc achieved in the IV. Quarter 2026 above company average sequential Revenue increase of 6.16%, to $ 1,588.30 millions, from $1,496.20 millions in the third quarter.

Within Medical Equipment & Supplies industry 29 other companies have achieved higher Revenue quarter on quarter growth. While Steris Plc's Revenue growth quarter on quarter, overall rank is 863.


Steris Plc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2026)
12 Months Ending
(Dec 31 2025)
12 Months Ending
(Sep 30 2025)
12 Months Ending
(Jun 30 2025)
12 Months Ending
(Mar 31 2025)
Cumulative Revenue 12 Months Ending $ 5,935.90 $ 5,828.13 $ 5,702.50 $ 5,571.11 $ 5,459.51
Y / Y Revenue Growth (TTM) 8.73 % 7.96 % 7.08 % 6.42 % 6.24 %
Year on Year Revenue Growth Overall Ranking # 2214 # 326 # 1193 # 925 # 1038
Seqeuential Revenue Change (TTM) 1.85 % 2.2 % 2.36 % 2.04 % 1.13 %
Seq. Revenue Growth (TTM) Overall Ranking # 2355 # 1783 # 1479 # 1623 # 1944


Cumulative Revenue growth Comment
Although Steris Plc's Annual Revenue growth year on year were below company's average 17.73% , Revenue announced in the Mar 31 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 8.73% year on year, from 7.96% in Dec 31 2025.

In the Healthcare sector 324 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 326 to 2214.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 126
Healthcare Sector # 325
Overall # 2214

Revenue TTM Y/Y Growth Statistics
High Average Low
81.61 %
17.73 %
-6.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 126
Sector # 345
S&P 500 # 2355
Cumulative Revenue growth Comment
Although Steris Plc's Annual Revenue growth year on year were below company's average 17.73% , Revenue announced in the Mar 31 2026 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 8.73% year on year, from 7.96% in Dec 31 2025.

In the Healthcare sector 324 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 326 to 2214.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 126
Healthcare Sector # 325
Overall # 2214

Revenue TTM Y/Y Growth Statistics
High Average Low
81.61 %
17.73 %
-6.58 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 126
Sector # 345
S&P 500 # 2355




Other Revenue Growth
Medical Equipment & Supplies Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
STE's Revenue Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue increase for the quarter ending Mar 31 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2026
Iradimed Corporation12.65%$ 12.651 millions
Dbv Technologies S a 12.50%$ 12.500 millions
Abbvie Inc 12.43%$ 12.433 millions
Novocure Limited12.30%$ 12.298 millions
Lemaitre Vascular Inc 11.74%$ 11.740 millions
Bausch Health Companies Inc 11.73%$ 11.731 millions
Orthopediatrics Corp11.73%$ 11.726 millions
Innoviva Inc 11.71%$ 11.705 millions
Boston Scientific Corporation11.60%$ 11.602 millions
Keenova Therapeutics Plc11.36%$ 11.360 millions
Aclarion Inc 11.32%$ 11.316 millions
Si bone inc 11.24%$ 11.241 millions
Pacs Group Inc 11.22%$ 11.224 millions
Sight Sciences Inc 11.02%$ 11.021 millions
Ss Innovations International Inc11.01%$ 11.010 millions
Royalty Pharma Plc10.97%$ 10.969 millions
Resmed Inc 10.87%$ 10.875 millions
Medline Inc 10.66%$ 10.656 millions
Rigel Pharmaceuticals Inc10.28%$ 10.284 millions
Msa Safety Inc10.27%$ 10.273 millions
Phibro Animal Health Corporation10.10%$ 10.101 millions
Johnson and Johnson9.91%$ 9.907 millions
Acadia Pharmaceuticals Inc 9.72%$ 9.719 millions
Sotera Health Company9.68%$ 9.683 millions
Universal Health Services Inc 9.65%$ 9.646 millions
Earth Science Tech Inc 9.46%$ 9.462 millions
Bausch and Lomb Corp9.41%$ 9.411 millions
Zimmer Biomet Holdings Inc 9.30%$ 9.303 millions
Avanos Medical Inc 9.23%$ 9.233 millions
Quest Diagnostics Inc9.16%$ 9.163 millions


About Steris Plc Revenue Growth Rates (STE), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.